Cadila Healthcare informs about press release

18 Jul 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated July 18, 2020 titled ‘Zydus Cadila receives final approval from USFDA for Butalbital, Acetaminophen and Caffeine Tablets’ .The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

948.50 -2.45 (-0.26%)
26-Apr-2024 11:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6248.80
Cipla 1407.80
Zydus Lifesciences 948.50
Lupin 1615.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.